z-logo
Premium
Transient exposure of human eosinophils to the protein kinase C inhibitors CGP39‐360, CGP41‐251, and CGP44‐800 leads to priming of the respiratory burst induced by opsonized particles
Author(s) -
Bruggen Tjomme,
Kbk Paul T.M.,
Blom Michela,
Verhoeven Arthur J.,
Raaijmakars Jan A.M.,
Lammers JanWillem J.,
Koenderman Leo
Publication year - 1993
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.54.6.552
Subject(s) - respiratory burst , protein kinase c , staurosporine , opsonin , priming (agriculture) , zymosan , biology , respiratory system , immunology , signal transduction , pharmacology , microbiology and biotechnology , biochemistry , phagocytosis , in vitro , anatomy , botany , germination
We report that a transient incubation of human eosinophils with the protein kinase C (PKG) inhibitor CGP39‐360 (staurosporine) or the more PKC‐specific inhibitors CGP41‐251 and CGP44‐800 prior to activation of the respiratory burst with opsonized particles results in priming of this response. This priming effect was concentration dependent and occurred in the range in which the phorbol myristate acetate‐induced respiratory burst was inhibited. CGP39‐360 priming was minimally affected in Ca 2+ ‐depleted cells, indicating that an increase in [Ca 2+ ]i is not important. Also, the binding of serum‐treated zymosan (STZ) particles was strongly enhanced by the inhibitors. On the other hand, the release of plateletactivating factor (PAF) induced by opsonized particles was enhanced only by CGP39‐360 and not by CGP41‐251 and CGP44‐800. Therefore, priming of the respiratory burst is not due to an aspecific enhancing effect of the inhibitors. These data indicate that different signal transduction routes are involved in priming of the STZ‐induced respiratory burst and PAF release in human eosinophils.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here